Eilon D. Kirson, Chief Science Officer at Novocure Ltd (NVCR), sold 15,000 shares at $15.06 ($226K) on 2017-06-19, disclosed to the SEC on 2017-06-21.
Open-market sale of $226k NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2018-04-20 | $3.5M | — | Filing → |
| NVCR | SELL | 2018-01-16 | $557K | — | Filing → |
| NVCR | SELL | 2017-11-08 | $200K | — | Filing → |